Regeneron’s planned acquisition of 23andMe raises significant privacy concerns as experts warn about the lack of comprehensive federal regulations governing the transfer of genetic information.
Related Posts
A Texas firm recently charged with conspiring to distribute synthetic…
Archaeologists recovered ancient hair from a cave in Menorca, one…